MERCK’s VASOTEC (ENALAPRIL) APPROVED FOR PREVENTION OF CHF

MERCK's VASOTEC (ENALAPRIL) APPROVED FOR PREVENTION OF CHF and "decreas[ing] the incidence of hospitalization" in "clinically stable asymptomatic patients with left ventricular dysfunction (ejection fraction [